Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
10/2009
10/28/2009CN101565452A Immune 7P truncated peptide and application thereof
10/28/2009CN100554278C Human tumor M2-type pyruvate kinase antigen determinant polypeptide and antibody and their application in diagnositic kit
10/27/2009US7608697 Mixture comprising enzymatic polypeptides with proline modified terminal for use in enhancing/reducing digestion/flavor/bitterness of foods; food processing
10/27/2009US7608696 Immunoglobulin for use in diagnosis and prognosis of metastatic breast cancer and degenerative neural conditions; drug screening; immunotherapy and diagnostics; anticarcinogenic agents
10/27/2009US7608691 Antibodies against IL-16 antagonist peptides
10/27/2009US7608687 Releasable linkage and compositions containing same
10/27/2009US7608683 Human leukocyte antigen pan DR-binding peptides for use in the treatment of infections, inflammatory, autoimmune and cancer diseases; has heat shock protein that is capable of binding to MHC class II molecules
10/27/2009US7608681 Methods and compositions for prolonging elimination half-times of bioactive compounds
10/27/2009US7608591 Targeted delivery to legumain-expressing cells
10/27/2009US7608577 Peptidyl ketones as inhibitors of DPIV
10/27/2009US7608280 Method of producing FR901228
10/27/2009US7608242 Peptide-chelate conjugates
10/27/2009CA2267084C Process for the one-stage resalting and purification of oligopeptides
10/22/2009WO2009129311A2 Somatostatin receptor 2 antagonists
10/22/2009WO2009129220A2 Plectin-1 targeted agents for detection and treatment of pancreatic ductal adenocarcinoma
10/22/2009WO2009129173A2 Methods, antibodies and kits for detecting cerebrospinal fluid in a sample
10/22/2009WO2009127845A1 Process for the preparation of network polymer compositions
10/22/2009WO2009127140A1 7p peptide and its derivant, the use thereof
10/22/2009WO2009127072A1 Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use
10/22/2009WO2009127048A1 Method of treating demyelinating diesase
10/22/2009WO2002087504A9 Methods for inhibiting tumor cell proliferation
10/22/2009WO2002044329A9 Receptor-mediated uptake of peptides that bind the human transferrin receptor
10/22/2009US20090264618 Compounds With a Branched Linker
10/22/2009US20090264373 Synthetic peptide amides and dimers thereof
10/22/2009US20090264370 Polypeptides homologous to vegf and bmp1
10/22/2009US20090264346 Macrocyclic peptides active against the hepatitis c virus
10/22/2009US20090264345 Macrocyclic peptides and methods for making and using them
10/22/2009US20090264344 cyclic polypeptide biodrug; NONHEMOLYTIC, MINIMAL IN VITRO CYTOTOXICITY; TREATMENT OF BACTERIAL, VIRAL INFECTION, ESPECIALLY ONE CAUSED BY HIV-1 RETROVIRUS OR OTHER SEXUALLY-TRANSMITTED PATHOGENS
10/22/2009US20090264338 Inhibitor of Insulin Multimer Formation
10/22/2009US20090263847 Lsr receptor, its activity, its cloning and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications
10/22/2009US20090263785 Modified HIV-1 Peptides and Use Thereof in the Detection of Anit-HIV Antibodies
10/22/2009US20090263410 Use of tgf-b1 inhibitor peptides in the preparation of an immune response modulating agent
10/22/2009US20090263320 Peptide-Based Compounds
10/22/2009CA2758829A1 Method of treating demyelinating disease
10/22/2009CA2758642A1 Methods, antibodies and kits for detecting cerebrospinal fluid in a sample
10/22/2009CA2758415A1 Plectin-1 targeted agents for detection and treatment of pancreatic ductal adenocarcinoma
10/22/2009CA2721470A1 Somatostatin receptor 2 antagonists
10/22/2009CA2721019A1 Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use
10/21/2009EP2110669A1 Methods for the identification of allo-antigens and their use for cancer therapy and transplantation
10/21/2009EP1761553B1 Tumor-associated peptides that bind to mhc-molecules
10/21/2009EP1423413B1 Peptidic compounds selectively binding to p-selectin
10/21/2009CN101563359A Michael systems as transglutaminase inhibitors
10/21/2009CN101560246A Thymopentin derivate, preparation method and application of derivate and compound containing derivate in preparing drugs
10/21/2009CN101560245A CTL epitope polypeptide of avian influenza H5N1 virus and application thereof
10/21/2009CN101559217A Oral administration route of 7P peptide and application thereof to prevention or treatment of nephritis
10/21/2009CN100551930C Peptides modulating caspase activation
10/20/2009US7605133 Isolated peptides to treat alpha-synuclein diseases
10/20/2009US7605120 peptides and/or conjugated peptides may be used as therapeutics or prophylactics for the treatment of diseases mediated by B1 activation, including inflammation and chronic pain states of inflammatory and neuropathic origin, septic shock, arthritis, osteoarthritis, angina, asthma, allergic rhinitis
10/20/2009US7604982 High-throughput screening method for intergrin antagonist and new peptide screened therefrom
10/20/2009US7604811 Inducing an immune response in mammals comprising administering an antigenic synthetic peptide containing Colonization FactorAntigen/I pilus protein T-cell epitopes encapsulated within a biodegradable matrix of glycolic acid-lactic acid copolymer; amino acid sequences; intestinal bioavailability
10/15/2009WO2009126349A2 Methods and compositions related to internalizing rgd peptides
10/15/2009WO2009124948A1 Opiorphin peptide derivatives as potent inhibitors of enkephalin - degrading ectopetidases
10/15/2009WO2009124932A1 Peptides for inhibiting the hpv-e6 oncoprotein
10/15/2009WO2009124721A1 Novel antimicrobial peptides
10/15/2009US20090259020 Highly fluorinated beta-amino acids and methods of making and using same
10/15/2009US20090258834 Plasma protein-binding ligands
10/15/2009US20090258820 Echinocandin/carbohydrate complexes
10/15/2009US20090258819 Reagents and Methods for Smooth Muscle Therapies
10/15/2009US20090258815 Antiviral peptide and antiviral agent
10/15/2009US20090258426 Preferred segments of neural thread protein and method of using the same
10/15/2009US20090258079 Biocompatible Block Copolymer, Use Thereof and Manufacturing Method Thereof
10/15/2009CA2720778A1 Opiorphin peptide derivatives as potent inhibitors of enkephalin - degrading ectopeptidases
10/15/2009CA2710554A1 Methods and compositions related to internalizing rgd peptides
10/14/2009EP2108698A1 Vascular endothelial cell-binding peptide
10/14/2009EP2108657A1 Peptides for inhibiting the HPV-E6 oncoprotein
10/14/2009EP2108655A1 Immune-modulating peptide
10/14/2009EP2108372A1 Novel antimicrobial peptides
10/14/2009EP1881008A9 Method for the in vitro diagnosis of alzheimer's disease using a monoclonal antibody
10/14/2009EP1622930B9 Template-fixed peptidomimetics as medicaments against hiv and cancer
10/14/2009EP1230268B1 Heteroclitic analogs of class i epitopes
10/14/2009EP1144447B1 Tuberculosis diagnostic test
10/14/2009CN101558081A Fibrin binding peptide conjugates for diagnostic and therapeutic applications
10/14/2009CN101558080A Modulation of angiogenesis by a-beta peptide fragments
10/14/2009CN101555274A Preparation method of polypeptide solid-phase synthesis bivalirudin crude product
10/14/2009CN101555273A Ligand polypeptide combined with Tie2 protein specificity and drug delivery system
10/14/2009CN101555272A Solid phase preparation method of carbetocin
10/14/2009CN101555271A Epitope minimum motif peptide of human zona pellucida protein
10/14/2009CN100549025C Heptapeptide prepared from thymopentin and pidotimod, and synthetic method
10/13/2009US7601801 polypeptide with binding to antigen and is recognized by cytotoxic T lymphocytes; use as cancer vaccine
10/13/2009US7601753 Pyrrolidine melanocortin-specific compounds
10/13/2009US7601694 Inhibiting angiogenesis, tumor growth and metastasis in the tissue of a mammal by administering to the mammal an active agent comprising an angiogenesis-inhibiting amount of a selective antagonist of denatured collagen type-IV
10/13/2009US7601691 PYY peptide or a functional derivative, coupled to a reactive group( michael acceptor, maleimides or succnimides) capable of reacting on a blood component so as to form a stable covalent bond
10/13/2009US7601690 Cross-linked glycopeptide-cephalosporin antibiotics
10/13/2009CA2438910C Amphoteric sterols and the use thereof in the production of ph-sensitive liposomes
10/08/2009WO2009124254A1 Nucleotide analogs
10/08/2009WO2009123188A1 Partial peptide of survivin presented on mhc class ii molecule and use thereof
10/08/2009WO2009123119A1 Antigen-and-drug vehicle comprising synthetic peptide, and mucosal vaccine using the same
10/08/2009WO2009122285A1 Oxitocin analogues
10/08/2009WO2009121483A1 Highly bridged peptides from actinomadura namibiensis
10/08/2009WO2009121176A1 Insulin-induced gene (insig) peptide compositions and methods for cytoprotection
10/08/2009WO2009092891A3 Modification of intrinsically disordered sequences for preparing vaccines
10/08/2009WO2001098526A9 Receptor fingerprinting, sensory perception, and biosensors of chemical sensants
10/08/2009US20090253896 Selective substrates for matrix metalloproteinases
10/08/2009US20090253895 Printable Materials
10/08/2009US20090253894 Method of polymyxin b recovery from fermentation broth
10/08/2009US20090253639 Opiorphin peptide derivatives as potent inhibitors of enkephalin-degrading ectopeptidases
10/08/2009US20090253638 Somatostatin Antagonists
10/08/2009US20090253636 Novel Antifungal Agent
10/08/2009US20090253635 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments
10/08/2009US20090253634 Methods and Compositions for the Treatment of Gastrointestinal Disorders
1 ... 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 ... 423